Viewing Study NCT05797168


Ignite Creation Date: 2025-12-24 @ 5:41 PM
Ignite Modification Date: 2025-12-25 @ 3:10 PM
Study NCT ID: NCT05797168
Status: RECRUITING
Last Update Posted: 2025-12-17
First Post: 2023-02-21
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors
Sponsor: AstraZeneca
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module